Global Ophthalmic Devices, Diagnostics and Surgical Equipment Market
Global Ophthalmic Devices, Diagnostics and Surgical Equipment Market Report 2023-2028, Featuring Alcon, Bausch + Lomb, Carl Zeiss, Coopervision, Essilorluxottica, Hoya, Menicon, Nidek, Nikon & Topcon
February 26, 2024 04:26 ET | Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. The...
Charting New Paths:
Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
February 23, 2024 13:50 ET | Spherix Global Insights
EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar...
Global Microelectromechanical Systems (MEMS) in the Medical Market
Microelectromechanical Systems (MEMS) in the Medical Industry: Global Market Expected to Surge to USD 7.2 Billion by 2028
February 23, 2024 04:43 ET | Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Microelectromechanical Systems (MEMS) in Global Medical Markets" report has been added to ResearchAndMarkets.com's offering. The Global...
Neurologists Report
Neurologists Report Frustration with Efficacy and Logistical Issues Around Eisai/Biogen’s Leqembi, According to Spherix Global Insights Neurologist Survey
February 22, 2024 15:04 ET | Spherix Global Insights
EXTON, PA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The 2023 announcement of newly approved disease-modifying therapy (DMT) Leqembi (lecanemab) for Alzheimer’s Disease (AD) sparked eager anticipation...
logo.png
Ashvattha Therapeutics Announces First Patient Enrolled in Expanded Phase 1/2 Study of Imaging Agent 18F-OP-801 in Additional Neurological Indications
February 22, 2024 08:30 ET | Ashvattha Therapeutics
The study will evaluate the safety, tolerability, and ability of 18F-OP-801 to cross the blood-brain barrier and selectively target neuroinflammation in individuals with amyotrophic lateral sclerosis,...
Ocular Logo.png
Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
February 22, 2024 07:30 ET | Ocular Therapeutix, Inc.
Industry Leader and Retina Expert, Pravin U. Dugel, MD, Becomes Executive Chair Jeffrey S. Heier, MD to become Chief Scientific Officer, Peter K. Kaiser, MD to be Medical Director, and Sanjay...
Global Refractive Surgery Devices Market
Refractive Surgery Devices Market to Reach USD 393.12 Million by 2030 - An Insightful Analysis of Industry Growth, Trends, and Forecasts
February 22, 2024 04:09 ET | Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Refractive Surgery Devices Market by Product Type (Aberrometers, Microkeratome, Ophthalmic Laser), Application (Astigmatism, Dry Eyes,...
Screen Shot 2023-09-14 at 1.49.15 PM.png
MEDIA RELEASE: The Ford government is starving local public hospitals to privatize them, charge health advocates
February 21, 2024 12:00 ET | Ontario Health Coalition
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- A new report, Robbing from the public to build the private: The Ford government’s hospital privatization scheme reveals that local hospitals in every...
US Ambulatory Surgical Centers Market
US Ambulatory Surgical Centers (ASCs) Market Insights 2024-2029: The Future of Outpatient Care in the US Accelerates with Ownership Revolution and Specialization Surge
February 21, 2024 09:57 ET | Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "US Ambulatory Surgical Centers Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The US Ambulatory...
MnM_logo_TM_JPG.JPG
Medical Lasers Market is Expected to Reach $8.3 Billion | MarketsandMarkets™
February 21, 2024 07:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Medical Lasers market in terms of revenue was estimated to be worth $4.8 billion in 2023 and is poised to reach $8.3 billion by 2028, growing at a CAGR of...